Vitamin supplementation in patients receiving pemetrexed for advanced non-small cell lung cancer

Lung Cancer

Volumn 82, Issue 3, 2013, Pages 511-

  De Marinis, Filippo ^a   Passaro, Antonio ^a   Clarke, Stephen ^b  

^a Oncological Pulmonary 1st Unit   (Italy)

^b ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; DEXAMETHASONE; FOLIC ACID; PEMETREXED;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; GASTROINTESTINAL TOXICITY; HUMAN; LETTER; LEUKOPENIA; LUNG NON SMALL CELL CANCER; NEUTROPENIA; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GLUTAMATES; GUANINE; HUMANS; LUNG NEOPLASMS; MALE; VITAMINS;

EID: 84887613407     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.09.003     Document Type: Letter

References (3)

1. Young Saing K., Jong-Mu S., Jin Seok A., Myung-Ju A., Keunchil P. The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer. Lung Cancer 2013, 81:231-235.
2. Scagliotti G.V., Parikh P., von Pawel J., Biesma B., Vansteenkiste J., Manegold C., et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008, 26:3543-3551.
3. Hanna N., Shepherd F.A., Fossella F.V., Pereira J.R., De Marinis F., von Pawel J., et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004, 22:1589-1597.